Drugs that contain Ketorolac Tromethamine; Phenylephrine Hydrochloride
1. List of Omidria drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9399040 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(6 months from now) | |
| US8173707 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(6 months from now) | |
| US9278101 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(6 months from now) | |
| US8586633 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(6 months from now) | |
|
US9399040
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(1 year, 2 days from now) | |
|
US8173707
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(1 year, 2 days from now) | |
|
US8586633
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(1 year, 2 days from now) | |
|
US9278101
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(1 year, 2 days from now) | |
| US9486406 | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Oct, 2033
(10 years from now) | |
| US9066856 | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Oct, 2033
(10 years from now) | |
| US9855246 | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Oct, 2033
(10 years from now) | |
|
US9486406
(Pediatric) | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Apr, 2034
(11 years from now) | |
|
US9066856
(Pediatric) | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Apr, 2034
(11 years from now) | |
Market Authorisation Date: 30 May, 2014
Treatment: Maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain
Dosage: SOLUTION;IRRIGATION
How can I launch a generic of OMIDRIA before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic